BETRF
BetterLife Pharma Inc.Company Information
- Company Name
- BetterLife Pharma Inc.
- CIK
- CIK0001464165
- Category
- Non-accelerated filer
- Ticker: Exchange
- BETRF: OTC
- Fiscal Year End
- January 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- BETRF
SEC filing data through
Insider Sentiment
- Last purchase
- 2013-09-24
- Last sale
- —
- Shares purchased (TTM)
- 35,000,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2019-06-17
- Price on filing date
- —
- 1-month reaction
- 5.78%
- 3-month reaction
- -14.97%
Balance Sheet
Values in millions ($)| Line item | 2019-04-30 | 2019-01-31 | 2018-10-31 | 2018-07-31 | 2018-04-30 | 2018-01-31 | 2017-10-31 | 2017-07-31 | 2017-04-30 | 2017-01-31 | 2016-10-31 | 2016-07-31 | 2016-04-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | |||||||||||||||||||
| Assets Current | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Income Tax Receivable | - | 0 | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Income Taxes Receivable | 0 | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Inventory Net | - | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deposits Assets Noncurrent | - | - | - | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | - | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Finite Lived Intangible Assets Net | 8 | 8 | 7 | 7 | 7 | 0 | 0 | - | - | - | - | - | - | ||||||
| Assets | 10 | 9 | 7 | 8 | 9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities And Stockholders Equity | |||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Due To Related Parties Current | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | |||||||||||||||||||
| Convertible Debt Current | 3 | 3 | 3 | 4 | 3 | - | - | 0 | 0 | 0 | 0 | - | - | ||||||
| Liabilities Current | 5 | - | 4 | - | - | - | 0 | 1 | 2 | 2 | 1 | 1 | 1 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | - | - | ||||||
| Notes Payable | 0 | - | - | - | - | 0 | 0 | - | - | - | - | - | - | ||||||
| Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Capital Lease Obligation | 0 | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Revenue Current | - | - | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Deferred Revenue | - | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 1 | - | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 6 | 5 | - | 4 | 4 | 1 | 0 | - | - | 2 | - | - | - | ||||||
| Common Stock Value | 23 | 21 | 17 | 14 | 14 | 10 | 8 | 7 | 7 | 7 | 7 | 7 | 7 | ||||||
| Additional Paid In Capital | 17 | 17 | 13 | 12 | 12 | 16 | 12 | 12 | 11 | 11 | 11 | 10 | 9 | ||||||
Stockholders Equity | |||||||||||||||||||
| Stockholders Equity | 3 | 4 | 3 | 3 | 5 | -0 | 0 | -1 | -2 | -1 | -1 | -1 | -1 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -37 | -35 | -27 | -24 | -22 | -26 | -20 | -21 | -21 | -21 | -20 | -19 | -18 | ||||||
| Liabilities And Stockholders Equity | 10 | 9 | 7 | 8 | 9 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Shares Issued | 106 | 97 | 96 | 88 | 88 | 82 | 80 | 76 | 76 | 76 | 76 | 76 | 75 | ||||||
| Shares Outstanding | 106 | 97 | 96 | 88 | 88 | 82 | 80 | 76 | 76 | 76 | 76 | 76 | 75 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBetterLife Pharma Inc. (BETRF) — SEC Financial Statements & Analysis
BetterLife Pharma Inc. (BETRF) is a pharmaceutical preparations company, incorporated in A1. BetterLife Pharma Inc. trades on OTC as: BETRF. BetterLife Pharma Inc. (BETRF)'s most recent SEC filing is a Form 10-Q for the period ended 2019-04-30, filed with the SEC on 2019-06-17. Based on that filing, BetterLife Pharma Inc. carries a market cap of $318.51M, a P/E ratio of -35.73x, a P/B ratio of 94.56x, an enterprise value of $321.40M, and an EV/EBITDA multiple of -48.50x. On profitability, it posts a Return on Equity (ROE) of -223.97%, a Return on Assets (ROA) of -97.10%, and a Return on Invested Capital (ROIC) of -107.00%. Per share, it reports EPS of $-0.09, diluted EPS of $-0.09, free cash flow per share of $-0.04, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 387.88% year-over-year and EPS growth of 322.56% year-over-year. On the balance sheet, it maintains a current ratio of 0.04x, a quick ratio of 0.02x, working capital of $-5.12M, a debt-to-equity ratio of 1.83x, a debt ratio of 0.65, an interest coverage ratio of -12.90x, free cash flow of $-4.21M (TTM), and net debt of $2.88M. Figures sourced from SEC EDGAR.
- Market Cap
- $318.51M
- P/E TTM
- -35.73x
- EPS TTM
- $-0.09
- P/B TTM
- 94.56x
- ROE TTM
- -223.97%
- ROA TTM
- -97.10%
- Debt To Equity
- 1.83x
- Free Cash Flow TTM
- $-4.21M
Data as of 2019-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is BetterLife Pharma Inc. in?
BetterLife Pharma Inc. (BETRF) operates in the Pharmaceutical Preparations industry.
What exchange does BETRF trade on?
BetterLife Pharma Inc. (BETRF) trades on the OTC.
Where is BetterLife Pharma Inc. incorporated?
BetterLife Pharma Inc. is incorporated in British Columbia, Canada.
When was BetterLife Pharma Inc. (BETRF)'s most recent SEC filing?
BetterLife Pharma Inc. (BETRF)'s most recent SEC filing is a Form 10-Q for the period ended 2019-04-30, filed with the SEC on 2019-06-17.
What is BETRF's market cap?
BetterLife Pharma Inc. (BETRF) has a market capitalization of $318.51M as of 2019-04-30.
What is BETRF's EPS (earnings per share)?
BetterLife Pharma Inc. (BETRF)'s trailing twelve month EPS is $-0.09 as of 2019-04-30.
What is BETRF's ROE (return on equity)?
BetterLife Pharma Inc. (BETRF)'s trailing twelve month Return on Equity (ROE) is -223.97% as of 2019-04-30.
What is BETRF's ROA (return on assets)?
BetterLife Pharma Inc. (BETRF)'s trailing twelve month Return on Assets (ROA) is -97.10% as of 2019-04-30.
What is BETRF's ROIC (return on invested capital)?
BetterLife Pharma Inc. (BETRF)'s trailing twelve month Return on Invested Capital (ROIC) is -107.00% as of 2019-04-30.
What is BETRF's EV/EBITDA?
BetterLife Pharma Inc. (BETRF)'s trailing twelve month EV/EBITDA is -48.50x as of 2019-04-30.